Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations.

  • Authors : Van Syoc E; Department of Biology, The Pennsylvania State University, University Park, Pennsylvania, USA.; Department of Animal Science, The Pennsylvania State University, University Park, Pennsylvania, USA.

Subjects: Metformin*/Metformin*/Metformin*/pharmacology ; Metformin*/Metformin*/Metformin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/microbiology

  • Source: MBio [mBio] 2024 Jun 12; Vol. 15 (6), pp. e0016924. Date of Electronic Publication: 2024 May 20.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The effect of metformin combined with liraglutide on gut microbiota of Chinese patients with type 2 diabetes.

  • Authors : Niu X; Department of Endocrinology, Changzhi Medical College Affiliated Heji Hospital, Changzhi, 046011, China.; Lu P

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Metformin*/Metformin*/Metformin*/therapeutic use ; Metformin*/Metformin*/Metformin*/pharmacology

  • Source: International microbiology : the official journal of the Spanish Society for Microbiology [Int Microbiol] 2024 Feb; Vol. 27 (1), pp. 265-276. Date of Electronic Publication: 2023 Publisher: Springer Nature Country of Publication: Switzerland NLM ID: 9816585 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluating the Efficacy of Type 2 Diabetes Polygenic Risk Scores in an Independent European Population.

  • Authors : Brīvība M; Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.; Atava I

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/genetics; Humans ; Genetic Risk Score

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 17; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.

  • Authors : Elbere I; Translational Omics Group, Latvian Biomedical Research and Study Centre, Riga, Latvia.; Orlovskis Z

Subjects: Metformin*/Metformin*/Metformin*/pharmacology ; Metformin*/Metformin*/Metformin*/therapeutic use ; Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/drug effects

  • Source: Gut microbes [Gut Microbes] 2024 Jan-Dec; Vol. 16 (1), pp. 2361491. Date of Electronic Publication: 2024 Jun 13.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101495343 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Metformin: update on mechanisms of action and repurposing potential.

  • Authors : Foretz M; Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France.; Guigas B

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Metformin*/Metformin*/Metformin*/pharmacology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Nature reviews. Endocrinology [Nat Rev Endocrinol] 2023 Aug; Vol. 19 (8), pp. 460-476. Date of Electronic Publication: 2023 May 02.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500078 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Precision Medicine in Diabetes.

  • Authors : Dawed AY; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK.; Haider E

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/genetics; Humans

  • Source: Handbook of experimental pharmacology [Handb Exp Pharmacol] 2023; Vol. 280, pp. 107-129.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902231 Publication Model: Print Cited Medium: Print ISSN: 0171-2004 (Print)

Record details

×
Academic Journal

Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis.

  • Authors : Zhang E; Shanghai Key Laboratory of Compound Chinese Medicines and The Ministry of Education (MOE) Key Laboratory of Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Department of Diabetes Complications & Metabolism, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/physiology ; Metformin*/Metformin*/Metformin*/pharmacology

  • Source: Nature communications [Nat Commun] 2022 Mar 03; Vol. 13 (1), pp. 1135. Date of Electronic Publication: 2022 Mar 03.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  18 results for ""Elbere I""